Status
Conditions
Treatments
About
Prospective study to evaluate the safety and immunogenicity of Butantan Influenza seasonal vaccine.
Full description
Prospective cohort study to evaluate safety (three days post vaccination) and immunogenicity (measured 21 days post vaccination) of one dose of Butantan Influenza vaccine.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
63 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal